Get Mystery Box with random crypto!

🚀 Robin Rocket

Logo of telegram channel robin_rocket — 🚀 Robin Rocket R
Logo of telegram channel robin_rocket — 🚀 Robin Rocket
Channel address: @robin_rocket
Categories: Economics
Language: English
Subscribers: 592
Description from channel

Do you want to earn 30-50% every month? Join my channel!

Ratings & Reviews

2.00

2 reviews

Reviews can be left only by registered users. All reviews are moderated by admins.

5 stars

0

4 stars

0

3 stars

1

2 stars

0

1 stars

1


The latest Messages 5

2021-09-20 23:30:10 Mayville Engineering $MEC is a manufacturer of metal structures and various metal components for mechanical engineering and other industries. The company supplies major manufacturers such as Deere, Paccar, Honda Motor and Caterpillar.
Target price from Jefferies - $25, upside potential +33%

Theses in favor of the company's growth:

• Promising deals. Last spring, $MEC announced a contract for the supply of components for a leading American fitness company, which is expected to become one of the top 10 customers by sales volume next year.

The deal could bring the company an additional $125 million in revenue and increase EBITDA by $18 million.

• Cyclicity. Most of $MEC's clients are from the industrial sector, which is dependent on market cycles. At the moment, there is some decline in the sector, which provides an excellent opportunity to form a position at attractive prices.

• Underestimation of the company. Analysts note that long-term growth from reshoring has not yet been incorporated in the $MEC quotes. The company's shares are traded with a forward EV / EBITDA of 4x. At the same time, this multiplier on average for industrial companies from Russell 2000 = 10x.

• Opportunities for acquisitions. The company often acquires smaller competitors. These deals reduce costs, generate new customers, expand product lines, and improve workflow efficiency. Analysts note that the company has sufficient funds to make new deals.

Fundamental indicators:

• Market cap = $375 million
• fwd P/E = 10x
• fwd P/E sectors = 30x

Not an investment recommendation.
2.1K viewsedited  20:30
Open / Comment
2021-09-20 20:48:45 Brookfield Infrastructure $BIP

Current price: $54.09
Target price: $57

Brookfield Infrastructure is a globally diversified company specializing in utilities, intermediate energy, transportation and data.

Assets generate predictable cash flows backed by long-term contracts and government-regulated rates. This gives the company money to pay out above average dividends - a yield of 3.5% at current share prices - and expand its operations.

Brookfield recently completed the acquisition of Canadian oil infrastructure company Inter Pipeline in a C$16 billion ($12.7 billion) deal.

Company growth is facilitated by a combination of higher rates on existing contracts, increased volumes and expansion projects.

Management expects additional growth potential of up to 5% per annum as the company makes more and more profitable acquisitions.

Not an investment recommendation.
2.1K views17:48
Open / Comment
2021-09-20 18:14:26 One more blue chip of US stock market

PepsiCo, Inc. $PEP
Current price: $154.13
Target price: $160-165

PepsiCo, Inc. is an American multinational food processing company, one of the leading manufacturers of soft drinks, food and snacks, serving customers and consumers in more than 200 countries and territories.

Continuous innovation and responsiveness to changing consumer preferences make the company a leader in North America in both the snacks and liquid soft drinks categories.

PepsiCo reported net revenues of $70 billion in 2020, an impressive increase from 2019, when the company reported net revenues of $67 billion.

Analysts expect PepsiCo's annual profit growth to accelerate from 5.3% pa ​​in the previous five years to 9.8% over the next five years.

During the pandemic, Pepsi gained millions of new customers in its food division. The Beverage Division was virtually flat on the back of a sharp increase in sales in supermarket chains.

Not an investment recommendation.
2.1K views15:14
Open / Comment
2021-09-20 16:14:11 Good morning!
#investor_morning

Toyota ($TM) unveils new 2022 Tundra pickup with new hybrid engine.

SpaceX's Tourism Mission is back on earth.

Lennar ($LEN) reports the results of the third quarter of fiscal year 2021.

Merck ($MRK) presents data on its cancer drug portfolio in conjunction with the 2021 European Society for Medical Oncology Congress.

The Biden administration is reportedly in talks to purchase 500 million doses of Pfizer ($PFE) to donate to poor countries, an announcement likely to be made in a few days.

Boeing ($BA) to build new Illinois plant to manufacture MQ-25 Stingray.

GRAVE WARNINGS On Friday, aides to President Joe Biden and local officials across the country asked US lawmakers to address government debt that they warn could lead to an economic crisis.

This week, Congress plans to consider legislation that will avoid defaults before the October deadline, when the Treasury Department estimates it will no longer be able to pay all the country's bills.

Baker Hughes, an oilfield services company, released data on US drilling activity on Friday evening. The number of active drilling rigs increased by 10 rigs up to 411. After Hurricane 10 out of 14 mouth still remain closed.
2.1K views13:14
Open / Comment
2021-09-17 23:02:48 KLA Corporation $KLAC overview

Current price: $369
Target price: $380-390

KLA Corporation is an American company providing process control systems, revenue management and solutions to the semiconductor and other nanoelectronic industries.

KLA's comprehensive services also include the installation and maintenance of all products, the sale of spare parts, and staff training.

KLAC operates in the semiconductor equipment market, which is expected to grow at a CAGR of 8% between 2021 and 2026.

Revenue of KLA Corp. demonstrated a steady growth of 35.5% on average per year. The company dominates the market of metrological / instrumentation equipment, its capacity for 2021 is fully loaded.

KLA outperformed the main competitors in terms of key financial indicators and net profit.

KLAC has a long-term goal - to return >70% of free cash flow to shareholders through dividends / buybacks.

Not an investment recommendation.
2.1K views20:02
Open / Comment
2021-09-16 20:56:06 Technical Analysis - Abercrombie&Fitch

Abercrombie&Fitch $ANF is an American retailer of casual wear for young people. The company operates a network of 854 stores worldwide.

Technical picture:

• $ANF quotes formed a bullish ABC reversal pattern in August 2020, then the security traded in an uptrend until it peaked at $47 in early June.

• Quotes have set several new local highs and lows throughout their rally, facing support at the 21-day exponential moving average and 50-day simple moving average.

• From early April to late May, the security traded in a bullish price consolidation. Then, the $ANF quotes bounced off the 50-day simple moving average for significant volume, breaking the top of the consolidation for a minor breakout.

• Over the past 11 weeks, shares have shown significant declines and have moved into the oversold zone on the daily chart. On September 8, quotes dropped to the 200-day simple moving average and rebounded, which could serve as a potential bullish signal.

Abercrombie&Fitch $ANF
• Support Level - $31
• Resistance level - $42
• Take profit - $39-42
• Stop Loss - $31

Not an investment recommendation.
2.1K views17:56
Open / Comment
2021-09-16 19:07:06 Is eBay no longer a competitor to Amazon?

One of the most famous sites for online sales is currently undergoing a transformation process, the goal of which is to increase business margins by selling its low-income divisions. This will likely benefit eBay, which will affect the value of the stock.

eBay $EBAY is an American company that is one of the largest platforms in the world for online sales and auctions.
Target price - $88, upside potential +23%

Theses in favor of the company's growth:

• Concentration on high-margin areas.
• Business restructuring. eBay is actively selling low-yielding assets.
• Potential for organic growth.
• Optimistic forecasts of analysts.

Fundamental indicators:

• Market Cap: $46.7 billion
• fwd P / E = 18.7x
• fwd P / E sectors = 14.5x
• PEG = 1.46x

My view: The sale of some of the company's divisions that do not generate significant income is a logical step that will improve financial results. The launch of new services can significantly increase the attractiveness of the Internet site, which will lead to organic growth in revenue. Against this background, buying eBay shares can be a profitable long-term investment.

Not an investment recommendation.
2.1K views16:07
Open / Comment
2021-09-16 17:24:06 You can take such companies forever but now it is absolutely ideal to fix +5%

Microsoft Corporation $MSFT

Current price: $304
Target price: $320

Microsoft Corporation is an international technology company. Founded in 1975, founders - Bill Gates, Paul Allen.

Out of the outstanding historical facts: in the first year of operation, the company, which had only 3 people in its staff, worked with a turnover of $16 thousand, and in 2018. Microsoft is an international IT corporation with a total of 131,000 employees and a turnover of $64.5 billion. Today, it is one of the most expensive public companies in the world, in the ranking of the largest US corporations in terms of total income, it is included in the TOP-30.

Microsoft shares are up 34% YTD.

It is now the second largest company in the world with a market cap of $2.23 trillion.

Microsoft generated $61.3 billion in net income in fiscal 2021 in the last reporting quarter, which equates to $8.05 earnings per share.

The company is nearing completion of its latest share buyback program. Of the $40 billion he started with in February 2020, he had only $8.7 billion left as of June 30, following a $6.2 billion share buyback during the fourth quarter.

The company's $22 billion contract to build AR headsets for the US Army means the company will focus on using VR/AR in the government and corporate sectors.

Not an investment recommendation.
2.0K views14:24
Open / Comment
2021-09-16 15:53:06 Good morning!
#investor_morning

Capitol Police urged National Guard to prepare for possible rallies of Trump supporters on September 18

Amazon-backed Rivian plans to raise up to $8 billion in IPO $AMZN

Southwest Airlines introduces new employee vaccination incentive programs. Vaccinated workers will receive a bonus for 16 hours of work. At the same time, the company will cancel pay protection for employees who have not received the vaccine by mid-November $LUV

Chevron's CEO explained why the oil giant's investment in low-carbon technologies is targeting hydrogen rather than solar or wind power. “We have come to the conclusion that the management of our company cannot create value for shareholders using wind and solar energy,” he told $CVX

White House continues to discuss Biden's and Xi Jinping's interactions with China

Yesterday, a chain of coffee shops and a competitor of Starbucks, Dutch Bros., entered the New York stock exchange. The stock soared 60% on the first day. Starbucks shares fell 3.5%. Market cap after Wednesday close was $6.1 billion $BROS

AMC will accept Ehtereum, Litecoin along with bitcoins - CoinGape $AMC

FDA Accepts Intellia Therapeutics' application for research on new drug NTLA-5001 $NTLA
2.1K views12:53
Open / Comment
2021-09-15 22:27:06 Everyone's favorite pharma that can rise x2 I'm sure you will appreciate this survey.

Esperion Therapeutics, Inc., $ESPR
Current price: $11.20
Target price: $20-25

Esperion Therapeutics, Inc. is a pharmaceutical company dedicated to the development and commercialization of affordable oral nestatin drugs for the treatment of patients with elevated low density lipoprotein (LDL) cholesterol.

Esperion recently reported mixed second quarter earnings with higher earnings per share and no revenue.

In the midst of the pandemic, Esperion launched two new drugs: Nexletol and Nexlizet.

The company showed that NEXLETOL and NEXLIZET had a good quarter, with net revenues growing 67% and prescriptions up 28%.

In 2026, the annual sales of the Nexletol franchise to treat millions of people worldwide who cannot control their cholesterol with statins are expected to reach $1.8 billion.

Not an investment recommendation
2.2K views19:27
Open / Comment